Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Clasificación en acciones #19950
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Precio por acción
$4.06
Última sincronización: 2024-02-23
Capitalización bursátil
$145.61M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Theseus Pharmaceuticals, Inc. (THRX)

Categoría

Historial de desdoblamientos de acciones de Theseus Pharmaceuticals, Inc. (THRX)
La acción Theseus Pharmaceuticals, Inc. (símbolo: THRX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 25, 2026.
Una acción THRX comprada antes de Aug 25, 2026 equivaldría hoy a 0 acciones THRX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH